EU Institutions

The EU is a global leader in biotechnology, with the sector having expanded more than twice as fast as the overall economy in recent years. Yet, it faces significant challenges when it comes to scaling up EU-based production. Despite rapid advancements in biotech R&D, critical health products...

As Europe redefines its role in an increasingly complex geopolitical and economic landscape, the Mediterranean is emerging as a strategic crossroads for growth, security, and regional cooperation. Positioned at the intersection of Europe, the Middle East, and North Africa, Cyprus is uniquely placed to...

Menopause is a universal life stage, yet it remains largely invisible in policy debates—despite its far-reaching implications for health systems, labour markets, and gender equality. In the EU, rising life expectancy and rapid population ageing mean that more women will spend decades post-menopause,...

Europe is at a pivotal moment for its industrial base. The ongoing energy disruption combined with intensifying global competition and strategic dependencies, is reshaping how Europe powers its economy and sustains industrial strength. High energy costs, access to clean technologies, resilient supply chains, and skilled labour have become central to Europe’s competitiveness,...

“Rare Diseases in a Changing and Competitive Europe: Shaping policies to address the unmet needs of people living with rare diseases”  EURORDIS – Rare Diseases Europe will host the biennial European Conference on Rare Diseases and Orphan Products (ECRD 2026)...

Women’s health — and menopause in particular — is gaining increasing attention across Europe, as policymakers and healthcare experts recognise its significant impact on public health, workforce participation, and gender equality.  Building on previous discussions in the European Parliament, this flagship breakfast...

As legislators review the Biotech Act, they face a generational opportunity to strengthen Europe’s clinical trials landscape and its global competitiveness. The Commission’s proposal outlines changes that can help reverse Europe’s declining share in global clinical research, bridge the emerging...

Biotechnology is becoming a decisive capability for Europe’s competitiveness, industrial resilience and strategic autonomy. But Europe enters the next institutional cycle with a fragmented policy landscape, uneven regulatory capacity, and persistent scale-up barriers. The Commission’s Biotech Communication I and Biotech...

Now in its 22nd edition, the MEP Awards celebrate the excellence, dedication, and impact of Members of the European Parliament (MEPs), their Assistants (APAs), and Parliament staff. As MEPs enter the second year of their mandate, this year’s gala dinner...

At a time of shifting global alliances, rising demand for resilient supply chains, and renewed focus on strategic partnerships, the relationship between the EU and Mercosur is entering a defining moment. As both regions navigate economic uncertainty, decarbonisation, and evolving...